申请人:Merck & Co., Inc.
公开号:US04091101A1
公开(公告)日:1978-05-23
6-(1-Piperazinyl)quinoxaline and pharmaceutically acceptable salts thereof have serotoninmimetic activity. It is prepared by reducing the nitro group of 1-(3-amino-4-nitrophenyl)piperazine followed by treatment with glyoxal.
6-(1-哌嗪基)喹啉及其药学上可接受的盐具有类似于血清素的活性。它是通过还原1-(3-氨基-4-硝基苯基)哌嗪的硝基基团,然后用乙二醛处理而制备的。